Stockscreener 앱 받기
0.321
2.01%
-0.0066
시간 외 거래:
.32
-0.001
-0.31%
Mangoceuticals Inc 주식(MGRX)의 최신 뉴스
Mangoceuticals, Inc. (MGRX) Stock Price & News - Syfe
Form 13D/A MANGOCEUTICALS For: 6 October By Investing.com - Investing.com South Africa
Form 13D/A MANGOCEUTICALS For: 6 October By Investing.com - Investing.com India
Form 13D/A MANGOCEUTICALS For: 6 October By Investing.com - Investing.com Canada
Form 4 Mangoceuticals Inc For: 6 October - Investing.com India
CFO receives 100,000 shares at Mangoceuticals (MGRX), holds 220,000 directly afterward. - Stock Titan
A CEO stock bonus is issuable instead of a change-of-control payment at Mangoceuticals (MGRX). - Stock Titan
With 1.63M option shares included, Mangoceuticals (MGRX) CEO reports his ownership stake. - Stock Titan
For board services, Mangoceuticals (MGRX) director Alex P. Hamilton received 100,000 shares. - Stock Titan
Mangoceuticals (MGRX) Shares Fall 12% After Hours: Here's Why - Benzinga
Mangoceuticals Announces $2.5 Million Subsidiary-Level Investment in MangoRx IP Holdings to Advance Antiviral Portfolio Commercialization - Quiver Quantitative
Mangoceuticals Secures $2.5 Million Strategic Investment in MangoRx IP Holdings; Receives Initial $1.75 Million Tranche - GlobeNewswire Inc.
Investors agreed to buy 25% of Mangoceuticals’ company holding antiviral patents for $2.5 million. - Stock Titan
Mangoceuticals Secures $2.5 Million Strategic Investment in - GlobeNewswire
Mangoceuticals Terminates Planned Business Combination with Nuclea - The Globe and Mail
Mangoceuticals Terminates Planned Business Combination with Nuclea - TipRanks
Mangoceuticals And Nuclea Energy Terminate Business Combination Agreement On August 19 - TradingView
Mangoceuticals Terminates Nuclea Energy Business Combination After $15 Million PIPE Not Secured - TradingView
Mangoceuticals Company Profile & Introduction - Moomoo
MGRX Stock Alert: Halper Sadeh LLC is Investigating Whether Mangoceuticals, Inc. is Obtaining a Fair Price for its Shareholders - businesswire.com
MANGOCEUTICALS, INC. Q2 2026: Revenue $68.76K, EPS $(0.09) — 10-Q Summary - TradingView
Mangoceuticals (MGRX) Q2 2026 loss shrinks while cash and revenue fall - Stock Titan
Mangoceuticals, Inc. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2026 - marketscreener.com
12 Consumer Staples Stocks Moving In Thursday's After-Market Session - Benzinga
Mangoceuticals: Acquisition of Moltex Brings Advanced Nuclear R&D, Backed by More Than C$96M in Private Investment and Public Funding From Canada and the DOE >MGRX - Moomoo
Nuclea’s planned Moltex deal could add 80 nuclear patents - Stock Titan
MGRX Q3 2025 Earnings: -$0.69 Per Share Loss and 8.16% Stock Decline Highlight Ongoing ChallengesEarnings Yield Analysis - vinanet.vn
Why is Mangoceuticals stock surging today? - Investing.com India
On Thursday, there are stocks with unusual volume. Let's take a look. - ChartMill
Why is Mangoceuticals stock surging today? By Investing.com - Investing.com South Africa
Why is Mangoceuticals stock surging today? By Investing.com - Investing.com Nigeria
Mangoceuticals’ Merger Partner, Nuclea Energy Inc., Signs MOU with New Mining Co. to Advance Behind-the-Meter Modular Reactor Deployment for High-Density Computing Infrastructure - The Manila Times
Mangoceuticals' Merger Partner, Nuclea Energy Inc., Signs MOU With New Mining Co. to Advance Behind-the-Meter Modular Reactor Deployment for High-Density Computing Infrastructure - Moomoo
Why is Mangoceuticals stock surging today? By Investing.com - Investing.com Canada
Why is Mangoceuticals stock surging today? - Investing.com India
Mangoceuticals (MGRX) merger partner Nuclea inks Utah nuclear test reactor MOU - Stock Titan
Why is Mangoceuticals stock surging today? - Investing.com
Mangoceuticals (MGRX) Stock Jumps Over 49% After Hours: Here's Why - Benzinga
Mangoceuticals (MGRX) Stock Jumps Over 49% After Hours: Here's Why - TradingView
Mangoceuticals merger partner Nuclea signs MOU with New Mining on modular reactor power for data centers - Bitget
Mangoceuticals Wins Nasdaq Extension Amid Nuclea Deal Progress - The Globe and Mail
Wondering what's happening in today's after-hours session? - ChartMill
Mangoceuticals’ Merger Partner, Nuclea Energy (“Nuclea”), Executes MOU with Utah Office of Energy Development - Yahoo Finance
Mangoceuticals’ Merger Partner, Nuclea Energy (“Nuclea”), Executes MOU with Utah Office of Energy Development - GlobeNewswire
Mangoceuticals Wins Nasdaq Extension Amid Nuclea Deal Progress - TipRanks
Mangoceuticals (NASDAQ: MGRX) wins more time on Nasdaq rules, advances Nuclea deal - Stock Titan
Mangoceuticals Granted 180-Day Extension by Nasdaq to Regain Compliance with Minimum Bid Price Requirement and Comments on Nuclea Energy Business Combination - The Manila Times
Mangoceuticals Granted 180-Day Extension by Nasdaq to Regain Compliance with Minimum Bid Price Requirement and Comments on Nuclea Energy Business Combination - Yahoo Finance
Mangoceuticals Inc. (MGRX) Slides 15% to $0.45 as Selling Pressure IntensifiesSmart Money Flow Stocks - dars.gov.et
Mangoceuticals Inc. (MGRX) Slides 15% to $0.45 as Selling Pressure IntensifiesFactor ETF Flow - vinanet.vn
0.72%
2.68%
자본화:
|
볼륨(24시간):